TD:
Can't find article. Can't even find May 15 issue. I show latest online issue as May 1. And April 15 just arrived in the mail.
They must have taken down the May 15 issue after having posted it?? Could you try to provide more detailed instructions for access?
I show this tickler for the 5/1 issue, but a search for DGI or Blume comes up empty......
Corporate Profile-
Phage display technology, according to Ton Logtenberg, Ph.D., president and CEO of Utrecht Biotechnology
Systems (U-BiSys), is one of the most versatile technologies around. "We are using it to identify drug targets,
drug candidates and even improve on the transgenic mouse.".
Yeah..... came to those conclusions soon after reading the tickler on that first release. Should have come back here and made that clear..... small relative to an insulin, a IGF-1, etc., but not relative to "small". And oral-active relative to big, from a "rationale" stand rather than a chemical (practical) one.
Nonetheless.... if you can find agonists by modifying inhibitors of peptide agonists, one does have potential collaborators like Alkermes and Emisphere. I'm interested in why Novo expanded the original deal..... was there any tickler in the article re. such??
Notice that the latest tickler at the bottom of NBSC releases (not DGI, so direct comparison isn't yet possible?) omits any mention of "oral"......
The Company, through DGI BioTechnologies, its majority-owned drug-lead-discovery operation, has
developed and patented a proprietary process that is expected to result in the discovery of novel therapeutics by generating
biologically active drug leads for known pharmaceutical targets.
Thanks, Rick |
